Bio Protocol vs Cartesi — how do they compare? Bio Protocol trades at Rp430.58 (market cap Rp974,32M, Rp147,16M 24h volume), while Cartesi trades at Rp437.88 (market cap Rp407,76M, Rp43,92M 24h volume). The key difference: Bio Protocol is far larger — about 2.4× Cartesi's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 932,9M / 1B CTSI (94%) for Cartesi. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Cartesi for 91 Days on average.
| BIO | CTSI | |
|---|---|---|
Market Cap | Rp974,32M | Rp407,76M |
Volume (24h) | Rp147,16M | Rp43,92M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 932,9M / 1B CTSI (94%) |
Typical Hold Time | 18 Days | 91 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Cartesi (CTSI) shows bullish technical momentum with current price at Rp450.01, trading near the pivot point of Rp448. The asset maintains strong market cap of Rp418.98M with 94% circulating supply. Technical indicators show bullish moving averages and strong trend strength (ADX 82.48), though oscillators remain neutral. Support levels hold at Rp439-Rp426, with resistance at Rp461-Rp483.
Overall outlook remains cautiously optimistic with strong technical momentum but limited recent ecosystem developments. Key opportunity lies in potential breakout above Rp461 resistance, while risks include typical crypto volatility and lack of major protocol updates. Investors should monitor volume patterns and network activity closely.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Cartesi (CTSI) is the first OS on the blockchain. It bridges the gap between mainstream software and blockchain, welcoming millions of new startups and their developers to blockchain by bringing Linux to blockchain applications. Cartesi combines a groundbreaking virtual machine, optimistic roll-ups, and side-chains to revolutionize the way developers create blockchain applications.
Read more on CTSI →